The Food and Drug Administration on Monday approved Pfizer COVID-19 boosters for 12- to 15-year-olds as schools reopen after the holiday break amid the omicron variant surge. PHOTO: The Pfizer Covid-19 vaccine is administered at a pop-up clinic offering vaccines and booster shots in Rosemead, Calif., Nov. 29, 2021. The risk of myocarditis after a third mRNA vaccine dose to protect against COVID-19 is about one-third of the risk with the second dose, Marks said. The FDA said some even younger children who are immunocompromised should be eligible to get the boosters as well. FDA authorizes Pfizer COVID-19 boosters for 12- to 15-year olds originally appeared on abcnews.go.com

Source: ABC News January 03, 2022 15:16 UTC